Tuesday, December 23, 2014

Deals

MegaCell, RCT sign bi-facial poly-crystalline technology transfer deal

December 22, 2014 · Leave a Comment 

  Italian PV manufacturer MegaCell has signed a co-development and licence agreement with RCT Solutions for bi-facial photovoltaic poly-cristalline technology. MegaCell will start initial industrial production at its Carmignano di Brenta facility in Padua, Italy, early next year. The company plans to use the technology for its expansion capacity project in Europe as well as for PV manufacturers interested in poly-cristalline bi-facial cells and modules. MegaCell said the agreement represented a major step for the global PV sector “given the uniqueness of the polycrystalline PV Bi-facial... [Read the full story]

Deal News

MegaCell, RCT sign bi-facial poly-crystalline technology transfer deal

December 22, 2014 · Leave a Comment 

  Italian PV manufacturer MegaCell has signed a co-development and licence agreement with RCT Solutions for bi-facial photovoltaic poly-cristalline technology. MegaCell will start initial industrial production at its Carmignano di Brenta facility in Padua, Italy, early next year. The company plans to use the technology for its expansion capacity project in Europe as well as for PV manufacturers interested in poly-cristalline bi-facial cells and modules. MegaCell said the agreement represented a major step for the global PV sector “given the uniqueness of the polycrystalline PV Bi-facial... [Read the full story]

Legal

Philips, Nintendo Resolve Patent Disputes; Reaches Patent License Agreement

December 2, 2014 · Leave a Comment 

  Koninklijke Philips Electronics NV (PHGFF.PK,PHG: Quote) said it has resolved the patent disputes and also reached a patent license agreement with Nintendo Co. Ltd. (NTDOY.PK). Therefore, the patent infringement proceedings that Philips had initiated in Germany, the UK, France and the USA against Nintendo’s Wii, Wii U and DS handheld products would end. Pursuant to the agreement, both the firms would cross-license portions of each company’s patent portfolio. The terms and financial details of the license deal are not disclosed. “We are very pleased to have reached this... [Read the full story]

Bio

MegaCell, RCT sign bi-facial poly-crystalline technology transfer deal

December 22, 2014 · Leave a Comment 

  Italian PV manufacturer MegaCell has signed a co-development and licence agreement with RCT Solutions for bi-facial photovoltaic poly-cristalline technology. MegaCell will start initial industrial production at its Carmignano di Brenta facility in Padua, Italy, early next year. The company plans to use the technology for its expansion capacity project in Europe as well as for PV manufacturers interested in poly-cristalline bi-facial cells and modules. MegaCell said the agreement represented a major step for the global PV sector “given the uniqueness of the polycrystalline PV Bi-facial... [Read the full story]

University Tech Transfer

RedHill Biopharma Acquires Technology from University of Minnesota

December 18, 2014 · Leave a Comment 

  TEL-AVIV, Israel, Dec. 18, 2014 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (“RedHill” or “Company”), an Israeli biopharmaceutical company primarily focused on late clinical-stage drugs for inflammatory and gastrointestinal diseases, including gastrointestinal cancers, today announced that it has entered into a license agreement with the University of Minnesota to acquire the rights to a patented technology to support the development of a commercial diagnostic test for detection of Mycobacterium avium subspecies paratuberculosis (“MAP”)... [Read the full story]

People

Boulder’s Innovation Center of the Rockies signs commercialization agreement with University of Wyoming

October 11, 2013 · Leave a Comment 

  The Innovation Center of the Rockies, a Boulder-based organization created to help research institutions commercialize technology, has entered into an agreement with the University of Wyoming, officials announced Tuesday. Financial terms of the agreement were not disclosed. The University of Wyoming is the first commercialization partner outside the state of Colorado for the nonprofit Innovation Center of the Rockies, which has inked similar deals with the University of Colorado, Colorado School of Mines, Colorado State University and the University of Denver. “I think that we’ve... [Read the full story]

Deals

MegaCell, RCT sign bi-facial poly-crystalline technology transfer deal

  Italian PV manufacturer MegaCell has signed a co-development and licence agreement with RCT Solutions for bi-facial photovoltaic poly-cristalline technology. MegaCell will start initial industrial production at its Carmignano di Brenta facility in Padua, Italy, early next year. The company plans to use the technology for its expansion capacity... Read more of this article


MacroGenics Enters Collaboration and License Agreement with Janssen

  Rockville, Maryland, Dec. 22, 2014 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases, today announced a global... Read more of this article


Stemiotics Licenses Modified RNA for Cell Reprogramming

  San Diego, CA (PRWEB) December 22, 2014—Stemiotics, Inc., a supplier of stem cell generation services, today announced it has licensed key intellectual property pertaining to the application of modified RNA from CELLSCRIPT, LLC of Madison, WI. CELLSCRIPT holds an exclusive license to a portfolio of issued and pending patents based on discoveries... Read more of this article


ONO and Gilead Announce Exclusive License Agreement

  OSAKA, Japan & FOSTER CITY, Calif.–(BUSINESS WIRE)– ONO PHARMACEUTICAL CO., LTD. (“ONO”) and Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the companies have entered into an exclusive license agreement for the development and commercialization of ONO-4059, ONO’s oral Bruton’s tyrosine kinase (BTK) inhibitor... Read more of this article


Neste Oil and Renewable Energy Group Enter into NEXBTL License Agreement

  Neste Oil Corporation of Finland and Renewable Energy Group, Inc. (NASDAQ: REGI), headquartered in Ames, Iowa, USA have entered into a Settlement and License Agreement whereby the parties have settled Neste Oil’s US patent infringement lawsuits against REG and REG’s Singapore patent infringement lawsuits against Neste Oil and REG... Read more of this article


Bioject and Immunomic Therapeutics Enter into an Agreement

  Tigard, OR and Hershey, PA (PRWEB) December 19, 2014 Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection technology, today announced that it has entered into an agreement with Immunomic Therapeutics, Inc. (ITI) for ITI to use the Biojects Biojector®-2000 needle-free injection device... Read more of this article


Cardiome Enters Development And Commercialization Agreement With Eddingpharm

  Vancouver, Canada, Dec 19, 2014 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that one of its subsidiaries has entered into an agreement with Eddingpharm to develop and commercialize BRINAVESS™ in China, Taiwan, and Macau and re-launch BRINAVESS in Hong Kong. Eddingpharm will be responsible for any clinical trials... Read more of this article


BioLineRx, Novartis to develop and commercialize Israeli-sourced drug candidates

  Clinical-stage biopharmaceutical company BioLineRx and Novartis Pharma have reached a multi-year strategic collaboration agreement to support the development and commercialization of Israeli-sourced drug candidates. As part of the partnership, both the firms will jointly evaluate both clinical and pre-clinical stage projects that will be identified... Read more of this article


Chimerix (CMRX), ContraVir Pharma Enter Strategic Collaboration

  DURHAM, N.C. and EDISON, N.J., Dec. 18, 2014 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX) a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, and ContraVir Pharmaceuticals, Inc. (OTCBB:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral... Read more of this article


ObjectVideo Patent Licensing Program Acquired By Avigilon For A Cash Consideration Of $80.3M

  Reston, Va., USA (December 18, 2014) – ObjectVideo, Inc., a technology and solutions company, and Avigilon Corporation (TSX: AVO), a leading global provider of end-to-end security solutions, announced today the sale of ObjectVideo’s intellectual property and patent licensing program to Avigilon for a cash consideration of $80.3 million. “From... Read more of this article


More Posts From Deals

Legal

Philips, Nintendo Resolve Patent Disputes; Reaches Patent License Agreement

  Koninklijke Philips Electronics NV (PHGFF.PK,PHG: Quote) said it has resolved... 


Acacia Subsidiary Enters into Settlement and Release Agreement with Axiom Process

  NEWPORT BEACH, Calif.–(BUSINESS WIRE)– Acacia Research Corporation... 


More Posts From Legal

University Tech Transfer

RedHill Biopharma Acquires Technology from University of Minnesota

  TEL-AVIV, Israel, Dec. 18, 2014 (GLOBE NEWSWIRE) — RedHill Biopharma... 


eSurface® Technologies Signs Licensing Agreement with Utah Valley University

  CARLSBAD, Calif.–(BUSINESS WIRE)--eSurface® Technologies (DBA of EarthOne... 


More Posts From University Tech Transfer